Gall Bladder DiseaseGBSACWCHANCT03533322
Gall Bladder Status Among Children With Chronic Haemolytic Anemia
An observational study of Gall Bladder Disease, run by Assiut University.
Trial summary
Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital. Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Read more about this study
- Who is it for?
- Ages 1 year to 18 years
- Conditions the study is for
- Gall Bladder Disease
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2018to 1 Oct 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: All patients admitted to Assiut university children Hospital 1 year study * 2.4.4 -Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, …): Full clinical history including (age of onset of chronic haemolytic anemia- type of chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea - splenectomy or not- frequency of admission) * Detailed clinical examination * Abdominal ultrasound * Plain KUB (kidney ureter bladder) x-rayif radiopaque stone. * Compelete blood count * Liver function test * C- reactive protein
Who may be able to join
- children between 1 :18 years known to have chronic haemolytic anemia.
Who cannot join
- children below 1 year and above 18 years children had past history of cholecystectomy
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Gall Bladder Status Among Children With Chronic Haemolytic Anemia Attending to Assuit University Children Hospital
Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital.
Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.
Read more
Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.
This work aims to a) to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.
- to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia.
Read the detailed description
Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.(1) They may be classified according to the means of hemolysis, being either intrinsic in cases where the cause is related to the red blood cell (RBC) itself, defects of red blood cell membrane production (as in hereditary spherocytosis and hereditary elliptocytosis), defects in hemoglobin production (as in thalassemia, sickle-cell disease and congenital dyserythropoietic anemia), defective red cell metabolism (as in glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency). or extrinsic in cases where factors external to the RBC dominate, acquired hemolytic anemia may be caused by immune-mediated causes, drugs and other miscellaneous causes. Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.(2) The gallbladder is a small pouch that sits just under the liver. The gallbladder stores bile produced by the liver. After meals, the gallbladder is empty and flat, like a deflated balloon. Before a meal, the gallbladder may be full of bile and about the size of a small pear. In response to signals, the gallbladder squeezes stored bile into the small intestine through a series of tubes called ducts. Bile helps digest fat.(3) Diseases affecting gall bladder in children as:a)Gallstones (cholelithiasis) for unclear reasons, substances in bile can crystallize in the gallbladder, forming gallstones which is common and usually harmless, gallstones can sometimes cause pain, nausea, or inflammation. b)Cholecystitis( Infection of the gallbladder), often due to a gallstone in the gallbladder. Cholecystitis causes severe pain and fever, and can require surgery when infection continues or recurs.c) Gallstone pancreatitis: An impacted gallstone blocks the ducts that drain the pancreas. Inflammation of the pancreas results, a serious condition.(4) While problems associated with the gallbladder are rare in children, almost 50 percent of children have gallstones. Many of them--between 80 percent and 90 percent--have no symptoms. However, even small stones in small children can cause problems , Gallstones are mainly categorized in three groups of cholesterol, pigment, and mixture, among which the mixture is more common. Imbalance in bile constituents,such as cholesterol,lecithin,andbilesalts,is the main cause of gallstone formation.(4-5) In children >70% of gallstones are the pigment type, these stones are mostly reported in cases with hemolytic disease, such as spherocytosis and sickle cell anemia, cirrhosis, bile tract infection, these stones are black-brown in color, the incidence increases progressively with age. In sickle-cell disease, the prevalence of pigment gallstones( was reported to be 10% to 15% in children under 10 years of age, it increased to 40% in those aged 10-18 years, and 50% in adults(6-7). The prevalence of gallstones in hereditary spherocytosis was 10% to 20% and in adult series it was 40%(7-8). In thalassemia, the reported figure is low (10% to 15%)(8-9). With longer survival of thalassemiapatients, higher prevalence of gallstones (50%) has been reported(9). The highest prevalence of gallstones have been reported in thalassemics with Gilbert's syndrome genotype(10). However, in a study on 64 patients with median age of 10 (range, 5 to 20) years with thalassemia major from Chandigarh, none had gallstones(11).
Risk factors
- Multiple blood transfusions: In patients who periodically receive blood transfusions, hemolysis of the transfused cells may supplement the chronic endogenous blood destruction as a factor in the formation of gallstones [11-12].
- High rates (20% by age of four years) of recurrent biliary tract obstruction in children with the sickle cell disease reported [13].
- Obesity: With the prevalence of childhood obesity on the rise, there is a need to be more aware of obesity-related comorbidity including gallbladder disease. No clear link between the diet and risk for cholelithiasis, though foods high in cholesterol and low in fiber may increase the risk [14].
- Inefficient and infrequent gallbladder contractions, which allow bile to sit in the gallbladder for long periods of time, resulting in an over concentrated bile that is conducive to stone formation [15].
1-Aim of the study:
- to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.
- to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia. 2-Patients and methods: All cases included in the study will be subjected to:
- Full clinical history including (age of onset of chronic haemolytic anemia- type of chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea - splenectomy or not- frequency of admission)
- Detailed clinical examination
- Abdominal ultrasound
- Plain KUB (kidney ureter bladder) x-ray if radiopaque stone.
- Compelete blood count
- Liver function test
- C- reactive protein Type of study: cross- sectional study Site of the study: Haematology ;general surgery units and out patient clinics ;emergency unit at Assuit university children hospital. Duration of the study: one year Inclusion crieteria: children between 1 :18 years known to have chronic haemolytic anemia. Exclusion crieteria: children below 1 year and above 18 years children had past history of cholecystectomy Data analysis : Data will be processed and analyzed using SPSS software and the results will be processed in tables and figures . Ethical consideration:
- Reviewing the proposal will be carried out before starting via the ethical committee of assuit faculty of medicine.
- The aim of the study will be explained to each patient before beginning of the process,written consent will be obtained from those who welcome to participate in the study.
- Privacy and confidentiality of all data will be assur
- Conditions
- Gall Bladder Disease
- Medical subject headings
- Gallbladder Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
prevelance of gall bladder diseases in children with chronic hemolytic syndrome
gall bladder diseases
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 May 2018
- Study start1 Oct 2018 (estimated)
- Primary completion1 Oct 2019 (estimated)
- Study completion1 Oct 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gall Bladder DiseaseStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shohnda Mohammed Nazeir, Assiut University
- Investigators
- abelatif abdelmoez, professor, Principal investigator, assiut universitypediatric hospitalshereen galal, assistprof, Principal investigator, assiut universitypediatric hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03533322
- Sponsor's protocol ID
- gallbladderstatusinchhemlytic
- Acronym
- GBSACWCHA
- Status last verified
- May 2018
- First submitted
- 11 May 2018
- Last updated
- 31 Jul 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Gall Bladder Status Among Children With Chronic Haemolytic Anemia Attending to Assuit University Children Hospital
- ClinicalTrials.gov ID
- NCT03533322
- Acronym / sponsor ID
- GBSACWCHA / gallbladderstatusinchhemlytic
- Conditions
- Gall Bladder Disease
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Oct 2018 (estimated)
- Primary completion
- 1 Oct 2019 (estimated)
- Study completion
- 1 Oct 2019 (estimated)
- First posted
- 23 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital.
Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.
Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.
This work aims to a) to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.
- to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia.
Detailed description
Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.(1) They may be classified according to the means of hemolysis, being either intrinsic in cases where the cause is related to the red blood cell (RBC) itself, defects of red blood cell membrane production (as in hereditary spherocytosis and hereditary elliptocytosis), defects in hemoglobin production (as in thalassemia, sickle-cell disease and congenital dyserythropoietic anemia), defective red cell metabolism (as in glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency). or extrinsic in cases where factors external to the RBC dominate, acquired hemolytic anemia may be caused by immune-mediated causes, drugs and other miscellaneous causes. Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.(2) The gallbladder is a small pouch that sits just under the liver. The gallbladder stores bile produced by the liver. After meals, the gallbladder is empty and flat, like a deflated balloon. Before a meal, the gallbladder may be full of bile and about the size of a small pear. In response to signals, the gallbladder squeezes stored bile into the small intestine through a series of tubes called ducts. Bile helps digest fat.(3) Diseases affecting gall bladder in children as:a)Gallstones (cholelithiasis) for unclear reasons, substances in bile can crystallize in the gallbladder, forming gallstones which is common and usually harmless, gallstones can sometimes cause pain, nausea, or inflammation. b)Cholecystitis( Infection of the gallbladder), often due to a gallstone in the gallbladder. Cholecystitis causes severe pain and fever, and can require surgery when infection continues or recurs.c) Gallstone pancreatitis: An impacted gallstone blocks the ducts that drain the pancreas. Inflammation of the pancreas results, a serious condition.(4) While problems associated with the gallbladder are rare in children, almost 50 percent of children have gallstones. Many of them--between 80 percent and 90 percent--have no symptoms. However, even small stones in small children can cause problems , Gallstones are mainly categorized in three groups of cholesterol, pigment, and mixture, among which the mixture is more common. Imbalance in bile constituents,such as cholesterol,lecithin,andbilesalts,is the main cause of gallstone formation.(4-5) In children >70% of gallstones are the pigment type, these stones are mostly reported in cases with hemolytic disease, such as spherocytosis and sickle cell anemia, cirrhosis, bile tract infection, these stones are black-brown in color, the incidence increases progressively with age. In sickle-cell disease, the prevalence of pigment gallstones( was reported to be 10% to 15% in children under 10 years of age, it increased to 40% in those aged 10-18 years, and 50% in adults(6-7). The prevalence of gallstones in hereditary spherocytosis was 10% to 20% and in adult series it was 40%(7-8). In thalassemia, the reported figure is low (10% to 15%)(8-9). With longer survival of thalassemiapatients, higher prevalence of gallstones (50%) has been reported(9). The highest prevalence of gallstones have been reported in thalassemics with Gilbert's syndrome genotype(10). However, in a study on 64 patients with median age of 10 (range, 5 to 20) years with thalassemia major from Chandigarh, none had gallstones(11).
Risk factors
- Multiple blood transfusions: In patients who periodically receive blood transfusions, hemolysis of the transfused cells may supplement the chronic endogenous blood destruction as a factor in the formation of gallstones [11-12].
- High rates (20% by age of four years) of recurrent biliary tract obstruction in children with the sickle cell disease reported [13].
- Obesity: With the prevalence of childhood obesity on the rise, there is a need to be more aware of obesity-related comorbidity including gallbladder disease. No clear link between the diet and risk for cholelithiasis, though foods high in cholesterol and low in fiber may increase the risk [14].
- Inefficient and infrequent gallbladder contractions, which allow bile to sit in the gallbladder for long periods of time, resulting in an over concentrated bile that is conducive to stone formation [15].
1-Aim of the study:
- to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.
- to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia. 2-Patients and methods: All cases included in the study will be subjected to:
- Full clinical history including (age of onset of chronic haemolytic anemia- type of chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea - splenectomy or not- frequency of admission)
- Detailed clinical examination
- Abdominal ultrasound
- Plain KUB (kidney ureter bladder) x-ray if radiopaque stone.
- Compelete blood count
- Liver function test
- C- reactive protein Type of study: cross- sectional study Site of the study: Haematology ;general surgery units and out patient clinics ;emergency unit at Assuit university children hospital. Duration of the study: one year Inclusion crieteria: children between 1 :18 years known to have chronic haemolytic anemia. Exclusion crieteria: children below 1 year and above 18 years children had past history of cholecystectomy Data analysis : Data will be processed and analyzed using SPSS software and the results will be processed in tables and figures . Ethical consideration:
- Reviewing the proposal will be carried out before starting via the ethical committee of assuit faculty of medicine.
- The aim of the study will be explained to each patient before beginning of the process,written consent will be obtained from those who welcome to participate in the study.
- Privacy and confidentiality of all data will be assur
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 1 year to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- All patients admitted to Assiut university children Hospital 1 year study * 2.4.4 -Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, …): Full clinical history including (age of onset of chronic haemolytic anemia- type of chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea - splenectomy or not- frequency of admission) * Detailed clinical examination * Abdominal ultrasound * Plain KUB (kidney ureter bladder) x-rayif radiopaque stone. * Compelete blood count * Liver function test * C- reactive protein
Key inclusion criteria (1 listed)
- children between 1 :18 years known to have chronic haemolytic anemia.
Key exclusion criteria (1 listed)
- children below 1 year and above 18 years children had past history of cholecystectomy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
prevelance of gall bladder diseases in children with chronic hemolytic syndrome
Time frame: one year
gall bladder diseases
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2018.
Related trials for Gall Bladder Disease
Active, not recruitingPhase 2/3
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Biliary Tract Cancer, Cholangiocarcinoma
Not yet recruitingPhase 4
Effect of Prophylactic Dexamethasone vs Placebo on Airway Dimensions Assessed by Ultrasonography in Patients Undergoing Laparoscopic Cholecystectomy
Airway Edema, Postoperative Complications
Not yet recruitingPhase 3
Hepatic Arterial Infusion Chemotherapy Versus Capecitabine as Adjuvant Therapy for Resected Biliary Tract Cancer
Biliary Tract Cancer, Cholangiocarcinoma
Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
Localized Malignant Solid Neoplasm, Anal Cancer
RecruitingPhase 2
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Solid Tumors, HER2 Mutation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
abelatif abdelmoez, professor principal investigator
assiut universitypediatric hospital
shereen galal, assistprof principal investigator
assiut universitypediatric hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Gall Bladder Disease, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact shohnda nazeir, master (01064195028, shahdmohammed2060@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
prevelance of gall bladder diseases in children with chronic hemolytic syndrome (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2018.